-
August 2023. Moreno-Ajona D, Pérez-Rodríguez A,
Goadsby PJ (June 2020). "
Gepants, calcitonin-gene-related
peptide receptor antagonists: what
could be their...
-
classes include triptans (first line option),
ergot alkaloids,
ditans and
gepants.
Migraines can also be
treated with
unspecific analgesics such as nonsteroidal...
- due to a more
favorable treatment profile.
Gepants may be used for
rescue as well as prevention. Some
gepants are
approved for
different purposes in different...
-
Calcitonin gene-related
peptide (CGRP)
receptor antagonists are a
class of
drugs that act as
antagonists of the
calcitonin gene-related
peptide receptor...
- "Ditans" such as Lasmiditan,
lacking vasoconstrictive effect, and the "
Gepants" such as
Ubrogepant and Rimegepant, are
attractive alternatives, albeit...
-
migraines are CGRP
monoclonal antibodies and CGRP
receptor antagonists (
gepants).
Zavegepant was
approved for
medical use in the
United States in March...
- (November 2022). "Focus on zavegepant: the
first intranasal third-generation
gepant". Pain Management. 12 (8): 879–885. doi:10.2217/pmt-2022-0054. PMID 36189708...
-
interfere with the
interaction of CGRP and its receptor. As a result, the
gepants such as
atogepant have been
developed and
introduced to
clinical use. He...
- medications, the ergots, the triptans, and the
promising newer drugs, the
gepants,
possess one
significant common denominator: they all
potently constrict...
